Our primary cell pipeline consists of a diverse list of high-quality human primary cells. Stringent recovery, isolation, and characterization protocols are being developed and established specifically for each cell type. Lot specific documentation will include cell characterization data as well as comprehensive donor history.
New Cells to Aid Lung Disease Research
The newest primary cells being developed include three types of lung epithelial cells - alveolar type II, bronchial, and small airway. All three cell types show initial viability over 80% with appropriate morphology and cell marker expression. Continued development of these cells is a key initiative of 2021 due to their wide range of suitable applications focused on respiratory diseases, particularly SARS-CoV2 (the causative COVID-19 agent) infection studies and SARS disease modeling. We are actively seeking co-development partners. For more information, view our news release or contact us.